Guardant Health
GH
#1003
Rank
ยฃ18.02 B
Marketcap
ยฃ134.29
Share price
1.75%
Change (1 day)
187.07%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Earnings for Guardant Health (GH)

Earnings in 2026 (TTM): -ยฃ0.35 Billion

According to Guardant Health 's latest financial reports the company's current earnings are ยฃ1.18 Billion. In 2025 the company made an earning of -ยฃ0.32 Billion, an increase over its 2024 earnings that were of -ยฃ0.33 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guardant Health from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ0.35 Billion7.96%
2025 -ยฃ0.32 Billion-4.03%
2024 -ยฃ0.33 Billion-9.12%
2023 -ยฃ0.37 Billion-26.73%
2022 -ยฃ0.5 Billion69.96%
2021 -ยฃ0.3 Billion56.35%
2020 -ยฃ0.19 Billion252.69%
2019 -ยฃ52.66 Million-17.22%
2018 -ยฃ63.62 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Neogen
NEOG
-ยฃ6.77 Million-98.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-ยฃ0.2 Billion-44.40%๐Ÿ‡บ๐Ÿ‡ธ USA